Sangui Biotech Financials
| SGBI Stock | USD 0.0002 0.00 0.00% |
Sangui |
Sangui Biotech Stock Summary
Sangui Biotech competes with Assertio Therapeutics, Amneal Pharmaceuticals,, and Lifecore Biomedical. Sangui Biotech International, Inc., through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany. Sangui Biotech is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US80105B1017 |
| Business Address | BleichenbrUecke 9, Hamburg, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.sanguibiotech.com |
| Phone | 49 40 609 3120 |
| Currency | USD - US Dollar |
Sangui Biotech Key Financial Ratios
Sangui Biotech's financial ratios allow both analysts and investors to convert raw data from Sangui Biotech's financial statements into concise, actionable information that can be used to evaluate the performance of Sangui Biotech over time and compare it to other companies across industries.| Return On Asset | -0.64 | |||
| Beta | 0.22 |
Sangui Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sangui Biotech's current stock value. Our valuation model uses many indicators to compare Sangui Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sangui Biotech competition to find correlations between indicators driving Sangui Biotech's intrinsic value. More Info.Sangui Biotech International is currently regarded as top stock in return on asset category among its peers. It also is currently regarded as top stock in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sangui Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sangui Biotech's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Sangui Biotech Inter Systematic Risk
Sangui Biotech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Sangui Biotech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourty-five with a total number of output elements of sixteen. The Beta measures systematic risk based on how returns on Sangui Biotech Inter correlated with the market. If Beta is less than 0 Sangui Biotech generally moves in the opposite direction as compared to the market. If Sangui Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Sangui Biotech Inter is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Sangui Biotech is generally in the same direction as the market. If Beta > 1 Sangui Biotech moves generally in the same direction as, but more than the movement of the benchmark.
Sangui Biotech January 31, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Sangui Biotech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sangui Biotech International. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sangui Biotech International based on widely used predictive technical indicators. In general, we focus on analyzing Sangui Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sangui Biotech's daily price indicators and compare them against related drivers.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 86.67 |
Complementary Tools for Sangui Pink Sheet analysis
When running Sangui Biotech's price analysis, check to measure Sangui Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sangui Biotech is operating at the current time. Most of Sangui Biotech's value examination focuses on studying past and present price action to predict the probability of Sangui Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sangui Biotech's price. Additionally, you may evaluate how the addition of Sangui Biotech to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |